Multiple myeloma patients in the U.S. will now have access to Rapid Novor‘s noninvasive and highly sensitive blood test for monitoring minimal residual disease activity, or the small number of cancer cells that remain in a patient’s body after treatment. The test, called EasyM, previously was…
Read more
Blocking the activity of a group of proteins called fatty acid-binding proteins (FABPs) may be a useful treatment strategy for multiple myeloma, a new study shows. “We’ve found that blocking the FABPs can prevent the growth of myeloma cells, mainly by slowing the cells’ proliferation [growth rate],” Michaela Reagan,…
Janssen and radio host and comedian D.L. Hughley are partnering to call attention to multiple myeloma in Black communities, with a goal of driving better patient outcomes. The national campaign, “That’s My Word,” will provide information and resources specifically for African Americans — who are at a…
While myeloma doesn’t have a cure yet, its prognosis has greatly improved due to an increase in available treatments.
Myeloma is a cancer that forms from a type of white blood cell called B-cells. Learn more about the disease here.
Mutations in critical oncogenes or tumor suppressor genes in B-cells can cause myeloma. Learn more about the causes here.
Symptoms vary from patient to patient and may be mild in the early stages. Learn more about the symptoms here.
Get regular updates to your inbox.
